ENGN

enGene Holdings Inc., a clinical-stage biotechnology company based in Saint-Laurent, Canada, specializes in developing innovative genetic medicines aimed at treating diseases impacting mucosal tissues and other organs. Leveraging advanced delivery technologies, enGene enhances the safety and efficacy of its proprietary therapeutic platform to meet significant unmet medical needs in genetic therapy. With a promising pipeline currently progressing through clinical trials, enGene is well-positioned to reshape the future of genetic medicine and improve patient outcomes across a range of therapeutic areas.